$OTLK news

The latest OTLK stock news: headlines, filings, AI summaries and sentiment for $OTLK, updated around the clock.

• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · September 30, 2026, 20:31 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · September 18, 2026, 20:31 UTC
• Outlook Therapeutics Gets FDA Approval for LYTENAVA in Wet AMD Treatment Yahoo Finance · July 28, 2026, 21:31 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · July 24, 2026, 21:02 UTC
• Outlook Therapeutics receives FDA approval for Lytenava, the first ophthalmic bevacizumab for wet AMD Seeking Alpha · July 24, 2026, 19:20 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · July 24, 2026, 10:03 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · July 16, 2026, 20:06 UTC
• Outlook Therapeutics Receives July 29 PDUFA Date for LYTENAVA Yahoo Finance · July 14, 2026, 18:08 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · June 26, 2026, 21:31 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · June 16, 2026, 12:46 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · June 1, 2026, 13:17 UTC
• Outlook Therapeutics, Inc. - 8-K Filing SEC EDGAR · May 18, 2026, 10:03 UTC
• Outlook Therapeutics Reports Missed Earnings and Revenue Forecasts Seeking Alpha · May 15, 2026, 21:18 UTC
• Outlook Therapeutics, Inc. - 10-Q Filing SEC EDGAR · May 15, 2026, 20:36 UTC